This assignment includes the conclusion of a framework agreement for the supply of cytostatics for a period of one year and tacitly renewable three times for one year each.
Plot 8: Jan Yperman Hospital does not participate.
BevacizumabSee II.2.1
CisplatinSee II.2.1
PaclitaxelSee II.2.1
CYTARABINESee II.2.1
FLUDARABINESee II.2.1
ETOPOSIDESee II.2.1
VinorelbineSee II.2.1
Folic Acid/Levofoleic AcidSee II.2.1
BendamustineSee II.2.1
Topotecan (hydrochloride)See II.2.1
CapecitabineSee II.2.1
CarboplatinSee II.2.1
GefitinibSee II.2.1
ANAGRELIDESee II.2.1
FulvestrantSee II.2.1
DocetaxelSee II.2.1
DoxorubicinSee II.2.1
EpirubicinSee II.2.1
FluorouracilSee II.2.1
GemcitabineSee II.2.1
IrinotecanSee II.2.1
OxaliplatinSee II.2.1